NVCR
NovoCure Ltd
3월 13일 4:00 PM ET (한국 3/14 05:00)
$12.06
+0.05 ▲ +0.42%
🌙 3월 13일 7:49 PM ET (한국 3/14 08:49)
$12.06
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -1.22 | Insider Own | 10.01% | Shs Outstand | 0.11B | Perf Week | -7.52% |
| Market Cap | 1.37B | Forward P/E | - | EPS next Y | 22.89% | Insider Trans | -1.33% | Shs Float | 0.10B | Perf Month | 14.86% |
| Enterprise Value | 1.16B | PEG | - | EPS next Q | -0.49 | Inst Own | 84.92% | Short Float | 8.91% | Perf Quarter | -8.77% |
| Income | -0.14B | P/S | 2.09 | EPS this Y | -23.77% | Inst Trans | 5.22% | Short Ratio | 4.68 | Perf Half Y | -5.26% |
| Sales | 0.66B | P/B | 3.98 | EPS next 5Y | 30.19% | ROA | -13.32% | Short Interest | 9.13M | Perf YTD | -6.73% |
| Book/sh | 3.03 | P/C | 3 | EPS past 3/5Y | -11.4% - | ROE | -38.89% | 52W High | -42.21% ($20.87) | Perf Year | -39.88% |
| Cash/sh | 4.02 | P/FCF | - | Sales past 3/5Y | 6.81% 5.8% | ROIC | -23.6% | 52W Low | 22.81% ($9.82) | Perf 3Y | -82.27% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 21.72% | Gross Margin | 74.54% | Volatility(W/M) | 4.93% 8.9% | Perf 5Y | -91.28% |
| Dividend TTM | - | EV/Sales | 1.77 | Sales Y/Y TTM | 8.28% | Oper. Margin | -23.47% | ATR (14) | 0.99 | Perf 10Y | -12.29% |
| Dividend Ex-Date | - | Quick Ratio | 2.71 | EPS Q/Q | 64.08% | Profit Margin | -20.79% | RSI (14) | 45.9 | Recom | 1.5 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.9 | Sales Q/Q | 8.11% | SMA20 | -4% ($12.56) | Beta | 0.77 | Target Price | $25.93 |
| Payout | - | Debt/Eq | 0.73 | Earnings | 2000000 | SMA50 | -5.08% ($12.71) | Rel Volume | 0.33 | Prev Close | $12.01 |
| Employees | 1605 | LT Debt/Eq | 0.7 | EPS/Sales Surpr. | 46.52% -0.03% | SMA200 | -10.74% ($13.51) | Avg Volume(3M) | 1.95M | Price | $12.06 |
| IPO | 2015/10/2 | Option/Short | Yes/Yes | Trades | 10309 | Volume | 653,145 | Change | 0.42% |
뉴스 로딩 중...